STOCK TITAN

Novan (NOVN) Stock News, Apr-Jul 2020

NOVN NASDAQ
Rhea-AI Summary

Novan, Inc. (Nasdaq: NOVN) will host its 2020 Annual Meeting of Stockholders (ASM) on July 28, 2020, at 9:30 a.m. ET via a live audio webcast due to the COVID-19 pandemic. Stockholders of record as of June 11, 2020, can vote electronically and ask questions during the meeting. Guests may listen but cannot submit questions. Online check-in starts at 9:15 a.m. ET. Novan is focused on using nitric oxide for treating various diseases, emphasizing its potential benefits in dermatology and women's health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
conferences
-
Rhea-AI Summary

Novan anticipates its cash position will cover costs for an additional Phase 3 pivotal trial for SB206, targeting molluscum treatment (B-SIMPLE4). The company has secured approximately $16.9 million since June 1, 2020, from stock purchase agreements and warrant exercises. Enrollment for the trial is set for September 2020, with top-line results expected in late Q2 2021, pending no COVID-19 disruptions. Notably, there are currently no FDA-approved therapies for molluscum, highlighting the unmet need SB206 aims to address.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.40%
Tags
-
Rhea-AI Summary

Novan, Inc. (Nasdaq: NOVN) will present a corporate overview at the Life Sciences Investor Forum on June 25, 2020, at 2:00 p.m. Eastern. CEO Paula Brown Stafford will lead the presentation, which will include a real-time Q&A session for investors. Attendees can access the live webcast via the Company's website. An archived version will be available post-event. Novan, a clinical development-stage biotechnology company, focuses on leveraging nitric oxide to treat various diseases, addressing significant unmet medical needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.41%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.64%
Tags